Clinical implications of the detection of circulating tumor cells in breast cancer patients

Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437

(2011) M. M. Reinholz et al.   CLINICAL CANCER RESEARCH

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

(2011) Bahriye Aktas et al.   GYNECOLOGIC ONCOLOGY

Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

(2010) S. Riethdorf et al.   CLINICAL CANCER RESEARCH

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

(2009) F.-C. Bidard et al.   ANNALS OF ONCOLOGY

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer

(2009) A Daskalaki et al.   BRITISH JOURNAL OF CANCER

Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer

(2009) Minetta C. Liu et al.   JOURNAL OF CLINICAL ONCOLOGY

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

(2009) Seigo Nakamura et al.   Breast Cancer

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

(2008) Mitra Tewes et al.   BREAST CANCER RESEARCH AND TREATMENT

Circulating tumor cells in metastatic breast cancer

(2008) Shaheenah Dawood et al.   CANCER

Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial

(2008) J.-Y. Pierga et al.   CLINICAL CANCER RESEARCH

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

(2007) F. Nole et al.   ANNALS OF ONCOLOGY